approval
saveREBLOZYL (LUSPATERCEPT-AAMT) — FDA approval
community read0 votes
Sponsor: CELGENE CORP. Form: POWDER. Route: SUBCUTANEOUS
view source ↗Data sources
last refreshed 6mo ago
Found something off?
drug timeline · 5
- approvalREBLOZYL (LUSPATERCEPT-AAMT) — FDA approvalFeb 27, 2026 · 266d ago
- approvalREBLOZYL (LUSPATERCEPT-AAMT) — FDA approvalMay 16, 2024 · 918d ago
- approvalREBLOZYL (LUSPATERCEPT-AAMT) — FDA approvalAug 28, 2023 · 1180d ago
- approvalREBLOZYL (LUSPATERCEPT-AAMT) — FDA approvalJul 8, 2022 · 1596d ago
- approvalREBLOZYL (LUSPATERCEPT-AAMT) — FDA approvalNov 8, 2019 · 2569d ago
comments(0)
5-min edit window · permanent after that